Related Experiment Video
Updated: Aug 5, 2026
High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
Optimization of contrast medium dosing using a body surface area-based protocol for preoperative CT
Hiroki Miyazaki1, Kouta Hirotaki2, Kotaro Takahashi1
1Department of Radiological Technology, National Cancer Center Hospital East, Kashiwa, Japan.
Purpose:
To evaluate whether a body surface area (BSA)-based adjusted body weight (AdBW) protocol stabilizes vascular and hepatic parenchymal enhancement during preoperative CT colonography-angiography (CTC-A).
Methods:
This retrospective single-center study included 221 consecutive patients with colorectal cancer who underwent preoperative CTC-A between January 2024 and March 2025. Examinations used either a total body weight (TBW)-based iodine protocol (600 mg I/kg; n = 113) or a BSA-based AdBW protocol (21.74 g I/m2; n = 108), both with a fixed 30-s injection duration. Contrast enhancement and contrast-to-noise ratio (CNR) were measured in the abdominal aorta (AA), superior mesenteric artery (SMA), inferior mesenteric artery (IMA), and hepatic parenchyma. Hepatic enhancement was defined as the attenuation difference between unenhanced and portal venous-phase images. Body weight-dependent variability was assessed using linear regression slopes and body weight-stratified analyses. Qualitative vascular visualization and liver metastasis conspicuity were assessed using a five-point scale by an abdominal radiologist and a colorectal surgeon.
Results:
Regression slopes for the TBW and AdBW protocols were 2.96 versus 0.13 HU/kg for the AA, 3.98 versus -0.39 HU/kg for the SMA, 4.53 versus 0.22 HU/kg for the IMA, and 0.42 versus -0.06 HU/kg for hepatic parenchyma, respectively. The AdBW protocol reduced body weight dependency for all enhancement parameters. In stratified analyses, vascular attenuation remained stable across all body weight groups with AdBW dosing (all p > 0.05). Hepatic enhancement was also more consistent, with median values maintained at approximately 57.5-61.1 HU. Qualitative assessment showed that vascular visualization and liver metastasis conspicuity remained clinically acceptable with the AdBW protocol.
Conclusion:
BSA-based AdBW dosing reduced body habitus-dependent variability in vascular and hepatic enhancement during preoperative CTC-A.
More Related Videos
Related Concept Videos
01:28Imaging Studies for Cardiovascular System V: CT
01:27Imaging Studies III: Computed Tomography
01:30Radiological Investigation I: X-ray and CT
01:26Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
01:14Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
01:10Computed Tomography
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...